Company Filing History:
Years Active: 1993
Title: The Innovations of Mehdi Paborji
Introduction
Mehdi Paborji is an accomplished inventor based in Liverpool, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable solutions for medical applications. His work has the potential to enhance the efficacy and safety of treatments involving mitomycin C.
Latest Patents
Mehdi Paborji holds a patent for "Stable solutions of mitomycin C." This patent discloses a stable solution of mitomycin C in propylene glycol or a propylene glycol/water mixture. The solutions are notable for their acceptable shelf-life of over 24 months at 4°C. They can be injected directly or diluted with water or other aqueous parenteral vehicles for administration.
Career Highlights
Paborji is associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work there focuses on innovative solutions that improve patient care and treatment outcomes. His expertise in pharmaceutical formulations has been instrumental in advancing the company's research initiatives.
Collaborations
Throughout his career, Mehdi Paborji has collaborated with notable colleagues, including Joseph B. Bogardus and Shreeram N. Agharkar. These collaborations have fostered a productive environment for innovation and have contributed to the success of various projects.
Conclusion
Mehdi Paborji's contributions to the field of pharmaceuticals, particularly through his patent on stable solutions of mitomycin C, highlight his role as an innovative inventor. His work continues to impact the medical community positively.